Key terms
About VYGR
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest VYGR news
Apr 17
5:07am ET
Optimistic Buy Rating for Voyager Therapeutics Amid Strong Pipeline and Strategic Partnerships
Apr 16
7:06am ET
Voyager announces selection of development candidate for GBA1 Program
Apr 03
10:52am ET
Biotech Alert: Searches spiking for these stocks today
Apr 02
4:24pm ET
Voyager Therapeutics Announces CFO Transition Plan and Appointment
Mar 19
9:53am ET
Snowflake, MongoDB downgraded to Sell: Wall Street’s top analyst calls
Mar 19
6:17am ET
Voyager Therapeutics: A Buy Rating on Breakthrough CNS Gene Therapy Innovations and Strategic Growth Potential
Mar 19
6:05am ET
Voyager Therapeutics initiated with a Buy at H.C. Wainwright
Mar 13
7:19am ET
Voyager Therapeutics appoints Toby Ferguson as CMO
Mar 06
5:15pm ET
Voyager Therapeutics: A Strong Buy on CNS Gene Therapy Advances and Strategic Partnerships
Mar 06
5:05pm ET
Voyager Therapeutics initiated with a Buy at Citi
Mar 05
7:25am ET
Voyager Therapeutics (VYGR) Receives a Rating Update from a Top Analyst
Mar 01
7:48am ET
Oppenheimer Sticks to Their Buy Rating for Voyager Therapeutics (VYGR)
Mar 01
4:58am ET
Voyager Therapeutics Buy Rating Affirmed Amid Strong Pipeline and Financial Health
Mar 01
1:18am ET
Voyager Therapeutics’ Promising Outlook in Gene Therapy: A Strong Buy Recommendation
Feb 29
8:02am ET
Analysts Conflicted on These Healthcare Names: Immunocore Holdings (IMCR), Voyager Therapeutics (VYGR) and Castle Biosciences (CSTL)
Feb 28
6:10pm ET
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR) and Warby Parker (WRBY)
Feb 26
7:16am ET
Voyager Therapeutics reports selection of gene therapy development candidate
Feb 20
7:06am ET
Voyager Therapeutics reports preclinical activity on tau silencing gene therapy
No recent press releases are available for VYGR
VYGR Financials
Key terms
Ad Feedback
VYGR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
VYGR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range